Halozyme Therapeutics, Inc. (HALO): Price and Financial Metrics
HALO Price/Volume Stats
| Current price | $54.25 | 52-week high | $70.50 |
| Prev. close | $53.55 | 52-week low | $42.01 |
| Day low | $53.44 | Volume | 1,290,497 |
| Day high | $54.76 | Avg. volume | 1,842,264 |
| 50-day MA | $58.41 | Dividend yield | N/A |
| 200-day MA | $56.26 | Market Cap | 6.68B |
HALO Stock Price Chart Interactive Chart >
Halozyme Therapeutics, Inc. (HALO) Company Bio
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies that target the tumor microenvironment. The company was founded in 1998 and is based in San Diego, California.
HALO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HALO Price Returns
| 1-mo | -22.65% |
| 3-mo | -11.04% |
| 6-mo | 12.09% |
| 1-year | 5.46% |
| 3-year | 17.91% |
| 5-year | 129.87% |
| YTD | 13.47% |
| 2024 | 29.36% |
| 2023 | -35.04% |
| 2022 | 41.51% |
| 2021 | -5.85% |
| 2020 | 140.89% |